Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126606211 | 12660621 | 1 | I | 20160712 | 20160804 | 20160817 | 20160817 | EXP | ZA-ASTELLAS-2016US031241 | ASTELLAS | 38.00 | YR | M | Y | 0.00000 | 20160817 | CN | GB | ZA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126606211 | 12660621 | 1 | PS | Amphotericin B, Liposome | AMPHOTERICIN B | 1 | Intravenous (not otherwise specified) | 50740 | 700 | MG | INJECTION | QD | |||||||
| 126606211 | 12660621 | 2 | SS | EMTRICITABINE W/TENOFOVIR DISOPROXIL FUMARATE | EMTRICITABINETENOFOVIR DISOPROXIL | 1 | Unknown | UNK, UNKNOWN FREQ. | 0 | TABLET | |||||||||
| 126606211 | 12660621 | 3 | SS | FLUCONAZOLE. | FLUCONAZOLE | 1 | Oral | UNK, ONCE DAILY | 0 | 800 | MG | FORMULATION UNKNOWN | QD | ||||||
| 126606211 | 12660621 | 4 | SS | TENOFOVIR DISOPROXIL FUMARATE. | TENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | UNK, UNKNOWN FREQ. | 0 | TABLET | QD | ||||||||
| 126606211 | 12660621 | 5 | C | ATAZANAVIR W/RITONAVIR | ATAZANAVIRRITONAVIR | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
| 126606211 | 12660621 | 6 | C | ACTRAPID INSULIN NOVO | 2 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126606211 | 12660621 | 1 | Meningitis cryptococcal |
| 126606211 | 12660621 | 2 | Antiretroviral therapy |
| 126606211 | 12660621 | 3 | Meningitis cryptococcal |
| 126606211 | 12660621 | 4 | Antiretroviral therapy |
| 126606211 | 12660621 | 5 | Product used for unknown indication |
| 126606211 | 12660621 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126606211 | 12660621 | DE |
| 126606211 | 12660621 | HO |
| 126606211 | 12660621 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126606211 | 12660621 | Meningitis cryptococcal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126606211 | 12660621 | 1 | 20160708 | 0 | ||
| 126606211 | 12660621 | 3 | 20160708 | 0 |